b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2291466/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Roles of TNF-\xce\xb1 gene polymorphisms in the occurrence and progress of SARS-Cov infection: A case-control study</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291466/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Infectious Diseases" /><meta name="citation_title" content="Roles of TNF-\xce\xb1 gene polymorphisms in the occurrence and progress of SARS-Cov infection: A case-control study" /><meta name="citation_authors" content="Shixin Wang, Maoti Wei, Yi Han, Keju Zhang, Li He, Zhen Yang, Bing Su, Zhilun Zhang, Yilan Hu, Wuli Hui" /><meta name="citation_date" content="2008" /><meta name="citation_volume" content="8" /><meta name="citation_doi" content="10.1186/1471-2334-8-27" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2291466/?report=abstract" /><meta name="citation_pmid" content="18312678" /><meta name="DC.Title" content="Roles of TNF-\xce\xb1 gene polymorphisms in the occurrence and progress of SARS-Cov infection: A case-control study" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Shixin Wang" /><meta name="DC.Contributor" content="Maoti Wei" /><meta name="DC.Contributor" content="Yi Han" /><meta name="DC.Contributor" content="Keju Zhang" /><meta name="DC.Contributor" content="Li He" /><meta name="DC.Contributor" content="Zhen Yang" /><meta name="DC.Contributor" content="Bing Su" /><meta name="DC.Contributor" content="Zhilun Zhang" /><meta name="DC.Contributor" content="Yilan Hu" /><meta name="DC.Contributor" content="Wuli Hui" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1186/1471-2334-8-27" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Roles of TNF-\xce\xb1 gene polymorphisms in the occurrence and progress of SARS-Cov infection: A case-control study" /><meta property="og:type" content="article" /><meta property="og:description" content="Host genetic factors may play a role in the occurrence and progress of SARS-Cov infection. This study was to investigate the relationship between tumor necrosis factor (TNF)-\xce\xb1 gene polymorphisms with the occurrence of SARS-CoV infection and its ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2291466/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2291466/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2291466/pdf/12879_2007_Article_618.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1A451FE99B02F10000000001140111.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2291466</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Infectious Diseases</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Infect Dis</span>. 2008; 8: 27. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Feb 29. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1471-2334-8-27" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1471-2334-8-27</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2291466</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18312678">18312678</a></div></div></div></div><h1 class="content-title">Roles of <em>TNF</em>-&#x003b1; gene polymorphisms in the occurrence and progress of SARS-Cov infection: A case-control study</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Wang%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321535795968" co-class="co-affbox">Shixin Wang</a>,<sup>#</sup><sup>1</sup> <a href="/pubmed/?term=Wei%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321476698144" co-class="co-affbox">Maoti Wei</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>#</sup><sup>2</sup> <a href="/pubmed/?term=Han%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321499628448" co-class="co-affbox">Yi Han</a>,<sup>1</sup> <a href="/pubmed/?term=Zhang%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321498943488" co-class="co-affbox">Keju Zhang</a>,<sup>1</sup> <a href="/pubmed/?term=He%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321498941344" co-class="co-affbox">Li He</a>,<sup>1</sup> <a href="/pubmed/?term=Yang%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321503202768" co-class="co-affbox">Zhen Yang</a>,<sup>1</sup> <a href="/pubmed/?term=Su%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321503200400" co-class="co-affbox">Bing Su</a>,<sup>3</sup> <a href="/pubmed/?term=Zhang%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321539319968" co-class="co-affbox">Zhilun Zhang</a>,<sup>4</sup> <a href="/pubmed/?term=Hu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321539317600" co-class="co-affbox">Yilan Hu</a>,<sup>2</sup> and  <a href="/pubmed/?term=Hui%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678" class="affpopup" co-rid="_co_idm140321470389952" co-class="co-affbox">Wuli Hui</a><sup>2</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140321535795968"><h3 class="no_margin">Shixin Wang</h3><p><sup>1</sup>Proteomics Laboratory, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Wang%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Shixin Wang</a></div></div><div id="_co_idm140321476698144"><h3 class="no_margin">Maoti Wei</h3><p><sup>2</sup>Department of Epidemiology, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Wei%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Maoti Wei</a></div></div><div id="_co_idm140321499628448"><h3 class="no_margin">Yi Han</h3><p><sup>1</sup>Proteomics Laboratory, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Han%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Yi Han</a></div></div><div id="_co_idm140321498943488"><h3 class="no_margin">Keju Zhang</h3><p><sup>1</sup>Proteomics Laboratory, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Zhang%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Keju Zhang</a></div></div><div id="_co_idm140321498941344"><h3 class="no_margin">Li He</h3><p><sup>1</sup>Proteomics Laboratory, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=He%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Li He</a></div></div><div id="_co_idm140321503202768"><h3 class="no_margin">Zhen Yang</h3><p><sup>1</sup>Proteomics Laboratory, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Yang%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Zhen Yang</a></div></div><div id="_co_idm140321503200400"><h3 class="no_margin">Bing Su</h3><p><sup>3</sup>Department of Respiratory, Pingjin Hospital, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Su%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Bing Su</a></div></div><div id="_co_idm140321539319968"><h3 class="no_margin">Zhilun Zhang</h3><p><sup>4</sup>Department for Emergency Diseases, Center for Disease Control and Prevention, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Zhang%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Zhilun Zhang</a></div></div><div id="_co_idm140321539317600"><h3 class="no_margin">Yilan Hu</h3><p><sup>2</sup>Department of Epidemiology, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Hu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Yilan Hu</a></div></div><div id="_co_idm140321470389952"><h3 class="no_margin">Wuli Hui</h3><p><sup>2</sup>Department of Epidemiology, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </p><div>Find articles by <a href="/pubmed/?term=Hui%20W%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18312678">Wuli Hui</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140321497941264_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140321497941264_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140321497941264_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140321497941264_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Proteomics Laboratory, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Department of Epidemiology, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </div><div class="fm-affl" lang="en" id="Aff3"><sup>3</sup>Department of Respiratory, Pingjin Hospital, Medical College of Chinese People\'s Armed Police Force, Tianjin, China </div><div class="fm-affl" lang="en" id="Aff4"><sup>4</sup>Department for Emergency Diseases, Center for Disease Control and Prevention, Tianjin, China </div><div><span class="fm-affl">Shixin Wang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@100-xhsW" class="oemail">moc.361@100-xhsW</a></span>.</div><div><a href="#idm140321497941264aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><sup>#</sup>Contributed equally.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140321497941264_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2007 Sep 30; Accepted 2008 Feb 29.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140321497941264_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Wang et al; licensee BioMed Central Ltd. 2008</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2291466/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Host genetic factors may play a role in the occurrence and progress of SARS-Cov infection. This study was to investigate the relationship between tumor necrosis factor (TNF)-<em>&#x003b1;</em> gene polymorphisms with the occurrence of SARS-CoV infection and its role in prognosis of patients with lung interstitial fibrosis and femoral head osteonecrosis.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">The association between genetic polymorphisms of <em>TNF-&#x003b1;</em> gene and susceptibility to severe acute respiratory syndromes (SARS) was conducted in a hospital-based case-control study including 75 SARS patients, 41 health care workers and 92 healthy controls. Relationships of TNF-&#x003b1; gene polymorphisms with interstitial lung fibrosis and femoral head osteonecrosis were carried out in two case-case studies in discharged SARS patients. PCR sequencing based typing (PCR-SBT) method was used to determine the polymorphisms of <em>TNF-&#x003b1;</em> gene in locus of the promoter region and univariate logistic analysis was conducted in analyzing the collected data.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Compared to TT genotype, the CT genotype at the -204 locus was found associated with a protective effect on SARS with OR(95%<em>CI</em>) of 0.95(0.90&#x02013;0.99). Also, TT genotype, CT and CC were found associated with a risk effect on femoral head necrosis with ORs(95%<em>CI</em>) of 5.33(1.39&#x02013;20.45) and 5.67(2.74&#x02013;11.71), respectively and the glucocorticoid adjusted OR of CT was 5.25(95%CI 1.18&#x02013;23.46) and the combined (CT and CC) genotype OR was 6.0 (95%<em>CI</em> 1.60&#x02013;22.55) at -1031 site of <em>TNF-&#x003b1;</em> gene. At the same time, the -863 AC genotype was manifested as another risk effect associated with femoral head necrosis with OR(95%<em>CI</em>) of 6.42(1.53&#x02013;26.88) and the adjusted OR was 8.40(95%CI 1.76&#x02013;40.02) in cured SARS patients compared to CC genotype.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">SNPs of <em>TNF-&#x003b1;</em> gene of promoter region may not associate with SARS-CoV infection. And these SNPs may not affect interstitial lung fibrosis in cured SARS patients. However, the -1031CT/CC and -863 AC genotypes may be risk factors of femoral head necrosis in discharged SARS patients.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Idiopathic Pulmonary Fibrosis, Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome, Head Necrosis, Severe Acute Respiratory Syndrome Patient</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p5" class="p p-first">\n<em>TNF</em>, the gene encoding tumour necrosis factor (TNF), resides in the central part (class III region) of the major histocompatibility complex (MHC) surrounded by a large number of other immunological genes [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014100">1</a>]. Because of the special locus of this gene, it can be deduced that this gene may associate with many diseases, and this hypothesis was confirmed by many research results [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014096">2</a>, <a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014101">3</a>]. TNF-&#x003b1; is a key mediator of the inflammatory response and is critical for host defense against a wide variety of pathogenic microbes. However, the over-expression of this cytokine may lead to badness in disease recovery. The dual role of TNF, acting as an agent of both innate immunity and inflammatory pathology, poses a considerable challenge for gene regulation [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014094">2</a>], and this regulation mainly located on promoter region of this gene. The capacity for cytokine production in an individual has a major genetic component, and striking differences existed among individuals in terms of their ability to produce cytokines. Several biallelic polymorphisms had been described within the <em>TNF-&#x003b1;</em> gene, including seven in the promoter region at positions -1031T&#x02192;C, -863C&#x02192;A, -857C&#x02192;T, -376G&#x02192;A, -308G&#x02192;A, -238G&#x02192;A and -163G&#x02192;A base pairs from the transcription start site [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014089">4</a>, <a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014078">5</a>]. Moreover, a number of studies had shown that the <em>TNF-&#x003b1;</em> promoter polymorphism had a significant effect on its transcriptional activity [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014099">6</a>, <a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199754">7</a>].</p><p id="__p6">Severe acute respiratory syndrome (SARS) is a newly described human infectious disease caused by a novel coronavirus-SARS-CoV. SARS-CoV infection is important because of its high infectivity and unpredictable clinical course, which is characterized by a high mortality rate [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014072">8</a>]. Till now, many researchers had reported that susceptibilities to infection SARS-CoV may associated with <em>HLA</em>, <em>MXA, OAS-1</em> and <em>CLEC4M</em> gene polymorphisms [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014074">9</a>&#x02013;<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199749">13</a>], yet these results were variable in different populations. For example, Ng reported that SARS-CoV infection was associated with <em>HLA-B*0703</em> and <em>HLA-DRB1*0301</em> in HongKong population [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014084">9</a>], however, Lin\'s results showed that <em>HLA-B*4601</em> and <em>HLA-B*5401</em> were closely related to SARS-CoV infection [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014083">10</a>]. Chan reported that <em>CLEC4M</em> was attributed to SARS-CoV infection [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199755">13</a>], but Zhi\'s results failed to support this conclusion.<sup>7</sup> These differences may be attributed to the study population used in each report, also the complex mechanism infection to SARS-CoV should be considered as another factor of these differences. In order to explore more host factors influencing the occurrence of SARS-CoV infection, we studied the polymorphisms of <em>TNF-&#x003b1;</em> gene at the promoter region, which had been ascribed to polymorphisms within the regulatory regions or signal sequences of cytokine genes [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014059">14</a>].</p><p id="__p7">After discharging from hospital, interstitial lung fibrosis was observed in SARS patients. Clinical data showed that the prevalence rate of this change was 21%(42/200) in cured SARS patients nine months from the discharge [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>]. TNF-&#x003b1; was one of the earliest cytokines implicated in the pathogenesis of lung fibrosis diseases and, together with IL-1, has been found to over-expressed in regenerated type II pneumocytes in human lung, thus enhanced fibroblast proliferation [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014065">16</a>]<em>TNF-&#x003b1;</em> polymorphisms have been discovered significantly associated with increased risk of developing pulmonary fibrosis [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199753">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014054">18</a>]. Given that genetic variation may potentially alter inflammation and fibrosis in the lung, the aim of this case-case control study was to examine the <em>TNF-&#x003b1;</em> polymorphisms with interstitial lung fibrosis in SARS patients.</p><p id="__p8">In spite of interstitial lung fibrosis in cured SARS patients, another sequela &#x02013; femoral head necrosis was also observed in this population and the prevalence rate was 22.07%(49/221) and 23.1%(18/78) in Tianjin and Beijing patients respectively [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>, <a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014064">19</a>]. The cause of this disease was still unknown and there were arguments about it. For example, some author considered SARS-CoV as the cause of femoral head necrosis, yet other authors disagreed with this view [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>, <a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014086">21</a>]. Previous studies showed that femoral head necrosis may caused by hormone usage [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>], yet our data failed to agree with this point. So, it need further study to explore the cause of this sequela and <em>TNF-&#x003b1;</em> polymorphisms were considered first in this report.</p><p id="__p9" class="p p-last">In this paper, we aimed to study whether polymorphisms in <em>TNF</em>-<em>&#x003b1;</em> promoter region were associated with SARS-CoV infection, development, and progression of interstitial lung fibrosis and femoral head necrosis in cure SARS patients.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Subjects</h3><p id="__p10" class="p p-first">This study was reviewed and approved by ethics committees in the Medical College of CPAFP. The study population comprised 75 SARS patients in Pingjin hospital, Tianjin, China, 41 health care workers of the same hospital, who had come into contact with SARS patients but had not developed into SARS, and 66 individuals having no contact history with SARS patients. Among 75 SARS patients, 55 could be classified into severe and light SARS according to their clinical condition history during the hospitalized period and this population also had the history of hormone therapy by reviewing the clinical treatment. Anti-SARS-CoV antibodies of the serum samples were tested by SARS ELISA kits (Huada Diagnostics Ltd, Beijing, China).</p><p id="__p11">Considered that the progression of interstitial lung fibrosis or femoral head necrosis may be affected by hormone therapy, hormone using dosage, method and lasting period were considered in this study when analyzing the associations between gene polymorphisms with disease. Three kinds of hormone were used in SARS patients including methylprednisolone, deltadehydrocortisone and dexamethasone. In order to simplify analyzing, deltadehydrocortisone and dexamethasone dosage were calculated into methylprednisolone using the following equation: 4 mg methylprednisolone = 5 mg deltadehydrocortisone = 0.75 mg dexamethasone. Lash therapy means more than 320 mg methylprednisolone were used in a single day.</p><p id="__p12">Cured SARS patients with interstitial lung fibrosis were diagnosed by respiratory experts according to CT results following the standard proposal for therapy and diagnosis of SARS patients issued by Chinese Ministry of Health in 2004 [<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>]. Interstitial lung fibrosis of SARS patients manifested as irregular patch and strip shadow or high density strip shadow and honeycomb interstitial lung fibrosis, these changes could combine with the bronchiectasis.</p><p id="__p13" class="p p-last">Femoral head necrosis was diagnosed using magnetic resonance imaging (MRI). An MRI scan of a normal femoral head would show uniformly high signal intensity on T1- and T2-weighting throughout the femoral head. Agree with one of the following image could be diagnosed as femoral head necrosis in SARS patients: Abnormal signal with clear margin in cartilage of femoral head, or double thread image, or fracture or joint dent under cartilage, or T1WI low signal, T2WI and STIR high signal of the marrow cavity edema with blur edge [<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>].</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">Genomic DNA extraction and polymerase chain reaction</h3><p id="__p14" class="p p-first-last">Leucocytes were isolated within 12 h of blood collection using Percoll reagent. Then genomic DNA was extracted using cell DNA extraction kit (Tiangen BioTec Co, Beijing, China, patch number: 2004-08-13) according to the manufacturer\'s instructions. Primers were designed according to Gewaltig [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014055">23</a>]. Standard 50-&#x003bc;L polymerase chain reactions (PCRs) contained 5 &#x003bc;l(6.7 &#x003bc;M) forward primer 5\'-GATGGACTCACCAGGTGAG-3\', 5 &#x003bc;l(6.7 &#x003bc;M) reverse primer 5\'-CTCATGGTGTCCTTTCCAGG-3\', 5 &#x003bc;l buffer [150 mm (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, 500 mM Tris-Cl(pH = 8.8), 500 &#x003bc;M EDTA-Na<sub>2</sub>,15 mM MgCl<sub>2</sub>,100 mM &#x003b2;-Mercaptoethanol], 0.5 &#x003bc;L DNA polymerase (Tiangen BioTec Co, Beijing, China), 3 &#x003bc;l DNA template. Amplification was carried out in a thermal cycler TC312 (Techne, Duxford Cambridge, UK) with cycle parameters of 5 min at 94&#x000b0;C (initial denaturation), 35 rounds of 94&#x000b0;C 30 s, 60&#x000b0;C 100 s and 72&#x000b0;C 150 s, and a final extension for 5 min at 72&#x000b0;C. The reactions were carried out in molecular BioProducts 200 &#x003bc;L capped tubes, as these gave optimal heat transfer in the thermal cycler.</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Sequencing of <em>TNF-&#x003b1;</em>gene fragments</h3><p id="__p15" class="p p-first-last">The <em>TNF</em>-&#x003b1; gene 1279 bp fragments in this paper were sequenced in double directions with forward primer 5\'-GATGGACTCACCAGGTGAG-3\' and reverse primer 5\'-CTCATGGTGTCCTTTCCAGG-3\' and Invitrogen company (Invitrogen Co, Shanghai, China) using ABI 373 thermal cycler carried out this job. The homozygote genotype of each SNP site manifested as a single peak, yet the heterozygote with an ambiguous nucleotide position of a double color peak in the Big Dye chemistry pictures. According to reading the sequence graphs, the genotype was determined.</p></div><div id="Sec6" class="sec sec-last"><h3 id="Sec6title">Statistics</h3><p id="__p16" class="p p-first-last">The differences in values between two groups were evaluated by Chi analysis for frequencies or student <em>t</em> test for quantitative index and binary logistic regression was done using SPSS 11.5 software (SPSS Inc, Chicago, Illinois, USA).</p></div></div><div id="Sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec7title">Results</h2><div id="Sec8" class="sec sec-first"><h3 id="Sec8title">Demographic characteristics of the populations</h3><p id="__p17" class="p p-first-last">A total of 75 SARS patients, 41 health care workers and 66 individuals were included in this study. All the populations were Chinese Han ethnic. The mean age was 35.0 years for SARS, 35.7 for health care workers and 30.1 for individual controls (SARS <em>Vs</em> HCW, <em>P</em> &#x0003e; 0.05; SARS <em>Vs</em> individual control, <em>P</em> &#x0003e; 0.05). The proportion of male was 30.6% in SARS, 26.8% in health care workers and 69.5% in individual controls (SARS <em>Vs</em> HCW, <em>P</em> &#x0003e; 0.05; SARS <em>Vs</em> individual control, <em>P</em> &#x0003c; 0.05). The sera positive rate anti-SARS-CoV antibody was 100.0% in SARS, significantly higher than that of health care workers and individual controls (SARS <em>Vs</em> HCW, <em>P</em> &#x0003c; 0.05; SARS <em>Vs</em> individual control, <em>P</em> &#x0003c; 0.05) (Table <a href="/pmc/articles/PMC2291466/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1</span></span><span>1</span></a>).\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p18">Demographic characteristics of the populations</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321470013792" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">SARS (N = 75)</th><th align="center" rowspan="1" colspan="1">Health care workers (N = 41)</th><th align="center" rowspan="1" colspan="1">Control (N = 92)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age(years), mean [range]</td><td align="center" rowspan="1" colspan="1">35.0 [16-78]</td><td align="center" rowspan="1" colspan="1">35.7 [25-55]</td><td align="center" rowspan="1" colspan="1">30.1 [17-56]</td></tr><tr><td align="left" rowspan="1" colspan="1">Gender (Male/Female)</td><td align="center" rowspan="1" colspan="1">23/52</td><td align="center" rowspan="1" colspan="1">11/30</td><td align="center" rowspan="1" colspan="1">68/24</td></tr><tr><td align="left" rowspan="1" colspan="1">Positive rate of anti-SARS-CoV Ab</td><td align="center" rowspan="1" colspan="1">100.0%(75/75)</td><td align="center" rowspan="1" colspan="1">2.4%(1/41)</td><td align="center" rowspan="1" colspan="1">0.0%(0/92)</td></tr></tbody></table></div><div id="largeobj_idm140321470013792" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2291466/table/Tab1/?report=objectonly">Open in a separate window</a></div></div></div><div id="Sec9" class="sec"><h3 id="Sec9title"><em>TNF-&#x003b1;</em>polymorphisms and SARS-Cov infection</h3><p id="__p19" class="p p-first">\n<em>TNF-&#x003b1;</em> genotype frequencies were variable in SARS, health care workers and individual controls. There were no differences of <em>TNF-&#x003b1;</em> genotype distribution at the -1031(T&#x02192;C), -863(C&#x02192;A), -572(A&#x02192;C), -308(G&#x02192;A) and -238(G&#x02192;A) among the three populations. However, the CT genotype was less frequent in SARS group when compared with individual controls at the -204 locus (<em>X</em>\n<sup>2</sup> = 4.20, <em>P</em> = 0.04). Compared to TT genotype, the CT genotype at the -204 locus were found associated with a protective effect on SARS with OR(95%<em>CI</em>) of 0.95(0.90&#x02013;0.99) (Table <a href="/pmc/articles/PMC2291466/table/Tab2/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab2" rid-ob="ob-Tab2" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table2</span></span><span>2</span></a>).\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab2"><h3>Table 2</h3><!--caption a7--><div class="caption"><p id="__p20">\n<em>TNF</em>-&#x003b1; gene polymorphism in promoter region in cured SARS patients, health care workers and individual control</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321472483328" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">SNP site</th><th align="center" rowspan="1" colspan="1">SARS (%)</th><th align="center" rowspan="1" colspan="1">Health Care Workers (%)</th><th align="center" rowspan="1" colspan="1">Individual Control (%)</th><th align="center" rowspan="1" colspan="1">OR<sup>1</sup> (95%CI)</th><th align="center" rowspan="1" colspan="1">OR<sup>2</sup> (95%CI)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">-1031</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">TT</td><td align="center" rowspan="1" colspan="1">45(63.4)</td><td align="center" rowspan="1" colspan="1">25(64.1)</td><td align="center" rowspan="1" colspan="1">61(67.8)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">23(32.4)</td><td align="center" rowspan="1" colspan="1">13(33.3)</td><td align="center" rowspan="1" colspan="1">27(30.0)</td><td align="center" rowspan="1" colspan="1">0.98(0.43&#x02013;2.27)</td><td align="center" rowspan="1" colspan="1">1.12(0.59&#x02013;2.27)</td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">3(4.2)</td><td align="center" rowspan="1" colspan="1">1(2.6)</td><td align="center" rowspan="1" colspan="1">2 (2.2)</td><td align="center" rowspan="1" colspan="1">1.67(0.17&#x02013;16.88)</td><td align="center" rowspan="1" colspan="1">2.03(0.33&#x02013;12.68)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">79.6</td><td align="center" rowspan="1" colspan="1">80.8</td><td align="center" rowspan="1" colspan="1">74.5</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">20.4</td><td align="center" rowspan="1" colspan="1">19.2</td><td align="center" rowspan="1" colspan="1">25.5</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-863</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">55(73.3)</td><td align="center" rowspan="1" colspan="1">29(72.5)</td><td align="center" rowspan="1" colspan="1">64(70.3)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">19(25.3)</td><td align="center" rowspan="1" colspan="1">11(27.5)</td><td align="center" rowspan="1" colspan="1">27(29.7)</td><td align="center" rowspan="1" colspan="1">0.91(0.38&#x02013;2.17)</td><td align="center" rowspan="1" colspan="1">0.82(0.41&#x02013;1.63)</td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">1(1.3)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.98(0.94&#x02013;1.07)<sup>&#x00026;</sup>\n</td><td align="center" rowspan="1" colspan="1">2.16(1.78&#x02013;2.63)<sup>&#x00026;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">86.0</td><td align="center" rowspan="1" colspan="1">86.3</td><td align="center" rowspan="1" colspan="1">85.2</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">14.0</td><td align="center" rowspan="1" colspan="1">13.7</td><td align="center" rowspan="1" colspan="1">14.8</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-857</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">56(74.7)</td><td align="center" rowspan="1" colspan="1">31(77.5)</td><td align="center" rowspan="1" colspan="1">66(72.5)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">19(25.3)</td><td align="center" rowspan="1" colspan="1">8(20.0)</td><td align="center" rowspan="1" colspan="1">25(27.5)</td><td align="center" rowspan="1" colspan="1">1.32(0.52&#x02013;3.35)</td><td align="center" rowspan="1" colspan="1">0.90(0.45&#x02013;1.79)</td></tr><tr><td align="center" rowspan="1" colspan="1">TT</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1(2.5)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.03(0.97&#x02013;1.1)<sup>$</sup>\n</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">131(87.3)</td><td align="center" rowspan="1" colspan="1">70(87.5)</td><td align="center" rowspan="1" colspan="1">157(86.3)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">19(12.7)</td><td align="center" rowspan="1" colspan="1">10(12.5)</td><td align="center" rowspan="1" colspan="1">25(13.7)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-572</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">73(97.3)</td><td align="center" rowspan="1" colspan="1">40(97.6)</td><td align="center" rowspan="1" colspan="1">90(97.8)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">2(2.7)</td><td align="center" rowspan="1" colspan="1">1(2.4)</td><td align="center" rowspan="1" colspan="1">2(2.2)</td><td align="center" rowspan="1" colspan="1">1.10(0.10&#x02013;12.46)</td><td align="center" rowspan="1" colspan="1">1.23(0.17&#x02013;8.97)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">98.7</td><td align="center" rowspan="1" colspan="1">98.8</td><td align="center" rowspan="1" colspan="1">98.9</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">1.3</td><td align="center" rowspan="1" colspan="1">1.2</td><td align="center" rowspan="1" colspan="1">1.1</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-308</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">67(89.3)</td><td align="center" rowspan="1" colspan="1">39(95.1)</td><td align="center" rowspan="1" colspan="1">88(95.7)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">7(9.1)</td><td align="center" rowspan="1" colspan="1">2(4.9)</td><td align="center" rowspan="1" colspan="1">4(4.3)</td><td align="center" rowspan="1" colspan="1">2.04(0.40&#x02013;10.30)</td><td align="center" rowspan="1" colspan="1">2.30(0.65&#x02013;8.18)</td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">1(1.3)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.98(0.96&#x02013;1.01)<sup>&#x00026;</sup>\n</td><td align="center" rowspan="1" colspan="1">2.31(1.93&#x02013;2.77)<sup>&#x00026;</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">94.0</td><td align="center" rowspan="1" colspan="1">97.6</td><td align="center" rowspan="1" colspan="1">100.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">6.0</td><td align="center" rowspan="1" colspan="1">2.4</td><td align="center" rowspan="1" colspan="1">0.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-238</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">65(86.7)</td><td align="center" rowspan="1" colspan="1">39(95.1)</td><td align="center" rowspan="1" colspan="1">84(91.3)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">10(13.3)</td><td align="center" rowspan="1" colspan="1">2(4.9)</td><td align="center" rowspan="1" colspan="1">8(8.7)</td><td align="center" rowspan="1" colspan="1">3.00(0.63&#x02013;14.41)</td><td align="center" rowspan="1" colspan="1">1.62(0.60&#x02013;4.32)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">93.3</td><td align="center" rowspan="1" colspan="1">97.6</td><td align="center" rowspan="1" colspan="1">95.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">6.7</td><td align="center" rowspan="1" colspan="1">2.4</td><td align="center" rowspan="1" colspan="1">4.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-204</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">TT</td><td align="center" rowspan="1" colspan="1">75(100)</td><td align="center" rowspan="1" colspan="1">41(100.0)</td><td align="center" rowspan="1" colspan="1">87(94.6)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">0(0.0)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5(5.4)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">0.95(0.90&#x02013;0.99)<sup>$</sup>\n</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">97.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">2.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-163</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">74(98.7)</td><td align="center" rowspan="1" colspan="1">41(100.0)</td><td align="center" rowspan="1" colspan="1">87(94.6)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td></tr><tr><td align="center" rowspan="1" colspan="1">CG</td><td align="center" rowspan="1" colspan="1">1(1.3)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5 (5.4)</td><td align="center" rowspan="1" colspan="1">0.98(0.96&#x02013;1.01)<sup>&#x00026;</sup>\n</td><td align="center" rowspan="1" colspan="1">0.24(0.03&#x02013;2.06)</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">99.3</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">97.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">0.7</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">2.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140321472483328" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2291466/table/Tab2/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p21">Note: OR<sup>1</sup> was calculated by comparing SARS with HCW;</p><p id="__p22">OR<sup>2</sup> was calculated by comparing SARS with individual control;</p><p id="__p23">&#x00026;: Odds ratio replaced with SARS group; $: Odds ratio replaced with control</p></div></div><p id="__p24" class="p p-last">According to the clinical history, symptoms of SARS patients were classified into light and severe. Because of the complicated clinical condition during SARS outbreak, some patients\' histories were incomplete and could not be classified following the severity standard [<a href="#CR22" rid="CR22" class=" bibr popnode">22</a>]. The severe SARS referred to those with one or more of the following: (1) dyspnea, more than 30 times per min respiratory frequencies in still condition;(2) oxygenation index less than 300 mmHg; (3) shock or multiple organ dysfunction syndrome. Among all 75 patients, fifty-four were classified into light and severe. And there were no association of <em>TNF-&#x003b1;</em> polymorphisms and SARS severity (Table <a href="/pmc/articles/PMC2291466/table/Tab3/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab3" rid-ob="ob-Tab3" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table3</span></span><span>3</span></a>).\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab3"><h3>Table 3</h3><!--caption a7--><div class="caption"><p id="__p25">\n<em>TNF</em>-&#x003b1; gene polymorphism and the progress of SARS</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321499790064" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">SNP site</th><th align="center" rowspan="1" colspan="1">Severe SARS(%)</th><th align="center" rowspan="1" colspan="1">Light SARS(%)</th><th align="center" rowspan="1" colspan="1">OR* (95%CI)</th><th align="center" rowspan="1" colspan="1">\n<em>P</em>\n</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">-1031</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">TT</td><td align="center" rowspan="1" colspan="1">13(61.9)</td><td align="center" rowspan="1" colspan="1">22(73.3)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">7(33.3)</td><td align="center" rowspan="1" colspan="1">8(26.7)</td><td align="center" rowspan="1" colspan="1">1.48(0.44&#x02013;5.04)</td><td align="center" rowspan="1" colspan="1">0.53</td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">1(4.8)</td><td align="center" rowspan="1" colspan="1">0(0.0)</td><td align="center" rowspan="1" colspan="1">2.69(1.75&#x02013;4.14)<sup>&#x00026;</sup>\n</td><td align="center" rowspan="1" colspan="1">0.39</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">78.6</td><td align="center" rowspan="1" colspan="1">86.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">21.4</td><td align="center" rowspan="1" colspan="1">13.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-863</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">19(79.2)</td><td align="center" rowspan="1" colspan="1">24(80.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">5(20.8)</td><td align="center" rowspan="1" colspan="1">6(20.0)</td><td align="center" rowspan="1" colspan="1">1.05(0.28&#x02013;3.98)</td><td align="center" rowspan="1" colspan="1">0.60</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">89.6</td><td align="center" rowspan="1" colspan="1">90.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">10.4</td><td align="center" rowspan="1" colspan="1">10.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-857</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">15(62.5)</td><td align="center" rowspan="1" colspan="1">24(80.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">9(37.5)</td><td align="center" rowspan="1" colspan="1">6(20.0)</td><td align="center" rowspan="1" colspan="1">2.40(0.71&#x02013;8.11)</td><td align="center" rowspan="1" colspan="1">0.15</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">39(81.2)</td><td align="center" rowspan="1" colspan="1">54(90.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">9(18.8)</td><td align="center" rowspan="1" colspan="1">6(10.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-572</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">24(100.0)</td><td align="center" rowspan="1" colspan="1">29(96.7)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">0(0.0)</td><td align="center" rowspan="1" colspan="1">1(3.3)</td><td align="center" rowspan="1" colspan="1">1.83(1.43&#x02013;2.34)</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">98.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">1.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-308</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">20(83.3)</td><td align="center" rowspan="1" colspan="1">27(90.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">4(16.7)</td><td align="center" rowspan="1" colspan="1">2(6.7)</td><td align="center" rowspan="1" colspan="1">2.70(0.45&#x02013;16.22)</td><td align="center" rowspan="1" colspan="1">0.39</td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">0(0.0)</td><td align="center" rowspan="1" colspan="1">1(3.3)</td><td align="center" rowspan="1" colspan="1">1.74(1.36&#x02013;2.23)<sup>$</sup>\n</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">93.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">6.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-238</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">20(83.3)</td><td align="center" rowspan="1" colspan="1">27(90.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">4(16.7)</td><td align="center" rowspan="1" colspan="1">3(10.0)</td><td align="center" rowspan="1" colspan="1">1.80(0.36&#x02013;8.96)</td><td align="center" rowspan="1" colspan="1">0.69</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">91.70</td><td align="center" rowspan="1" colspan="1">95.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">8.3</td><td align="center" rowspan="1" colspan="1">5.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-204</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">TT</td><td align="center" rowspan="1" colspan="1">24(100.0)</td><td align="center" rowspan="1" colspan="1">30(100.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">100.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-163</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">24(100.0)</td><td align="center" rowspan="1" colspan="1">30(100.0)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1">100.0</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140321499790064" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2291466/table/Tab3/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p26">\n<strong>Note:</strong>*: OR was calculated using light SARS as control.</p><p id="__p27">&#x00026;: Odds ratio replaced with severity SARS group;</p><p id="__p28">$: Odds ratio replaced with light SARS</p></div></div></div><div id="Sec10" class="sec"><h3 id="Sec10title">Glucocorticoid using in SARS with interstitial lung fibrosis or femoral head necrosis</h3><p id="__p29" class="p p-first-last">Glucocorticoid using dosage, method and lasting period were not associated with interstitial lung fibrosis or femoral head necrosis in binary logistic analysis in SARS patients (Table <a href="/pmc/articles/PMC2291466/table/Tab4/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab4" rid-ob="ob-Tab4" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table4).</span></span><span>4</span></a>). And there was no difference of hormone using dosage between the interstitial lung fibrosis and non-interstitial lung fibrosis group(<em>t</em> = 0.72, <em>P</em> = 0.47) and this trend was also observed in the femoral head necrosis and non-femoral head necrosis group(<em>t</em> = 1.90, <em>P</em> = 0.064) (Table <a href="/pmc/articles/PMC2291466/table/Tab5/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab5" rid-ob="ob-Tab5" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table5</span></span><span>5</span></a>).\n\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab4"><h3>Table 4</h3><!--caption a7--><div class="caption"><p id="__p30">Binary logistic analysis of hormone using in SARS patients</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321479781904" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">Factors</th><th align="center" colspan="4" rowspan="1">Interstitial lung fibrosis</th><th align="center" colspan="4" rowspan="1">Femoral head necrosis</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">\n<em>P</em>\n</td><td align="center" rowspan="1" colspan="1">OR</td><td align="center" colspan="2" rowspan="1">95.0% C.I.</td><td align="center" rowspan="1" colspan="1">\n<em>P</em>\n</td><td align="center" rowspan="1" colspan="1">OR</td><td align="center" colspan="2" rowspan="1">95.0% C.I.</td></tr><tr><td align="left" rowspan="1" colspan="1">Glucocorticoid</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">0.11</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">0.99</td><td align="center" rowspan="1" colspan="1">1.00</td></tr><tr><td align="left" rowspan="1" colspan="1">Time</td><td align="center" rowspan="1" colspan="1">0.78</td><td align="center" rowspan="1" colspan="1">0.97</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="center" rowspan="1" colspan="1">1.18</td><td align="center" rowspan="1" colspan="1">0.96</td><td align="center" rowspan="1" colspan="1">1.00</td><td align="center" rowspan="1" colspan="1">0.84</td><td align="center" rowspan="1" colspan="1">1.18</td></tr><tr><td align="left" rowspan="1" colspan="1">Lash therapy</td><td align="center" rowspan="1" colspan="1">0.51</td><td align="center" rowspan="1" colspan="1">2.13</td><td align="center" rowspan="1" colspan="1">0.23</td><td align="center" rowspan="1" colspan="1">20.13</td><td align="center" rowspan="1" colspan="1">0.27</td><td align="center" rowspan="1" colspan="1">0.32</td><td align="center" rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1">2.43</td></tr><tr><td align="left" rowspan="1" colspan="1">Constant</td><td align="center" rowspan="1" colspan="1">0.68</td><td align="center" rowspan="1" colspan="1">3.48</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1">0.13</td><td align="center" rowspan="1" colspan="1">88.28</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140321479781904" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2291466/table/Tab4/?report=objectonly">Open in a separate window</a></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab5"><h3>Table 5</h3><!--caption a7--><div class="caption"><p id="__p31">Cumulative hormone usage (mg) in cured SARS patients classified according to interstitial lung fibrosis or femoral head necrosis</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321501251376" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th rowspan="1" colspan="1"></th><th align="center" rowspan="1" colspan="1">Mean &#x000b1; SD</th><th align="center" rowspan="1" colspan="1">Median</th><th align="center" rowspan="1" colspan="1">\n<em>P</em>\n<sub>25</sub>\n</th><th align="center" rowspan="1" colspan="1">\n<em>P</em>\n<sub>75</sub>\n</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">Interstitial lung fibrosis<sup>&#x00026;</sup>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">5188.13 &#x000b1; 2037.56</td><td align="center" rowspan="1" colspan="1">5140.00</td><td align="center" rowspan="1" colspan="1">3110.00</td><td align="center" rowspan="1" colspan="1">7288.75</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">4493.11 &#x000b1; 2528.91</td><td align="center" rowspan="1" colspan="1">3895.00</td><td align="center" rowspan="1" colspan="1">2720.00</td><td align="center" rowspan="1" colspan="1">5975.00</td></tr><tr><td align="center" rowspan="1" colspan="1">Femoral head necrosis<sup>&#x00026;&#x00026;</sup>\n</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">Yes</td><td align="center" rowspan="1" colspan="1">5672.31 &#x000b1; 2328.61</td><td align="center" rowspan="1" colspan="1">6090.00</td><td align="center" rowspan="1" colspan="1">3437.50</td><td align="center" rowspan="1" colspan="1">7872.50</td></tr><tr><td align="center" rowspan="1" colspan="1">No</td><td align="center" rowspan="1" colspan="1">4187.81 &#x000b1; 2389.71</td><td align="center" rowspan="1" colspan="1">3807.50</td><td align="center" rowspan="1" colspan="1">2355.00</td><td align="center" rowspan="1" colspan="1">5707.50</td></tr></tbody></table></div><div id="largeobj_idm140321501251376" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2291466/table/Tab5/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p32">&#x00026;: hormone dosage between interstitial lung fibrosis and non-interstitial lung fibrosis, <em>t</em> = 0.72, <em>P</em> = 0.47;</p><p id="__p33">&#x00026;&#x00026;: hormone dosage between femoral head necrosis and non-femoral head necrosis, <em>t</em> = 1.90, <em>P</em> = 0.064</p></div></div></div><div id="Sec11" class="sec"><h3 id="Sec11title"><em>TNF-&#x003b1;</em>polymorphisms and interstitial lung fibrosis</h3><p id="__p34" class="p p-first-last">Allele frequencies of <em>TNF-&#x003b1;</em> polymorphisms were listed in Table <a href="/pmc/articles/PMC2291466/table/Tab6/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab6" rid-ob="ob-Tab6" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table6</span></span><span>6</span></a> and there were no significant differences between interstitial lung fibrosis and non-interstitial lung fibrosis in SARS patients at promoter region of <em>TNF-&#x003b1;</em> gene.\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab6"><h3>Table 6</h3><!--caption a7--><div class="caption"><p id="__p35">\n<em>TNF</em>-&#x003b1; gene polymorphisms and the occurrence of interstitial lung fibrosis in SARS patients</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321497612032" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">SNP site</th><th align="center" rowspan="1" colspan="1">Interstitial lung fibrosis(%)</th><th align="center" rowspan="1" colspan="1">Non-interstitial lung fibrosis(%)</th><th align="center" rowspan="1" colspan="1">OR* (95%C.I.)</th><th align="center" rowspan="1" colspan="1">\n<em>P</em>\n</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">-1031</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">TT</td><td align="center" rowspan="1" colspan="1">14(70)</td><td align="center" rowspan="1" colspan="1">12(57.1)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">6(30)</td><td align="center" rowspan="1" colspan="1">8(38.1)</td><td align="center" rowspan="1" colspan="1">0.64(0.17&#x02013;2.38)</td><td align="center" rowspan="1" colspan="1">0.51</td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1(4.8)</td><td align="center" rowspan="1" colspan="1">1.08(0.93&#x02013;1.27)<sup>&#x02021;</sup>\n</td><td align="center" rowspan="1" colspan="1">0.48</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">85.00</td><td align="center" rowspan="1" colspan="1">76.19</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">15.00</td><td align="center" rowspan="1" colspan="1">23.81</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-863</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">17(77.3)</td><td align="center" rowspan="1" colspan="1">16(72.7)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">5(22.7)</td><td align="center" rowspan="1" colspan="1">6(27.3)</td><td align="center" rowspan="1" colspan="1">0.78(0.20&#x02013;3.08)</td><td align="center" rowspan="1" colspan="1">0.73</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">88.64</td><td align="center" rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">11.36</td><td align="center" rowspan="1" colspan="1">13.64</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-857</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">15(68.8)</td><td align="center" rowspan="1" colspan="1">17(77.3)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">7(31.8)</td><td align="center" rowspan="1" colspan="1">5(22.7)</td><td align="center" rowspan="1" colspan="1">1.59(0.42&#x02013;6.07)</td><td align="center" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">84.09</td><td align="center" rowspan="1" colspan="1">88.64</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">15.91</td><td align="center" rowspan="1" colspan="1">11.36</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-572</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">21(95.5)</td><td align="center" rowspan="1" colspan="1">22(100)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">1(4.5)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.96(0.87&#x02013;1.05)<sup>&#x00026;</sup>\n</td><td align="center" rowspan="1" colspan="1">0.50</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">97.73</td><td align="center" rowspan="1" colspan="1">100.00</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">2.27</td><td align="center" rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-308</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">21(95.5)</td><td align="center" rowspan="1" colspan="1">18(81.8)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">1(4.5)</td><td align="center" rowspan="1" colspan="1">4(18.2)</td><td align="center" rowspan="1" colspan="1">0.21(0.02&#x02013;2.10)</td><td align="center" rowspan="1" colspan="1">0.17</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">97.73</td><td align="center" rowspan="1" colspan="1">90.9</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">2.27</td><td align="center" rowspan="1" colspan="1">9.1</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-238</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">20(90.9)</td><td align="center" rowspan="1" colspan="1">18(81.8)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">2(9.1)</td><td align="center" rowspan="1" colspan="1">4(18.2)</td><td align="center" rowspan="1" colspan="1">0.45(0.07&#x02013;2.76)</td><td align="center" rowspan="1" colspan="1">0.33</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">95.45</td><td align="center" rowspan="1" colspan="1">90.9</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">4.55</td><td align="center" rowspan="1" colspan="1">9.1</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140321497612032" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2291466/table/Tab6/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p36">\n<strong>Note:</strong>*:OR was calculated using non-interstitial lung fibrosis as control.</p><p id="__p37">&#x00026;: Odds ratio replaced with interstitial lung fibrosis group;</p><p id="__p38">&#x02021;: Odds ratio replaced with non-interstitial lung fibrosis group</p></div></div></div><div id="Sec12" class="sec sec-last"><h3 id="Sec12title"><em>TNF</em>-&#x003b1; polymorphism and femoral head necrosis</h3><p id="__p39" class="p p-first-last">Allele frequencies of <em>TNF</em>-&#x003b1; gene were compared in SARS patients between femoral head necrosis and non-femoral head necrosis (Table <a href="/pmc/articles/PMC2291466/table/Tab7/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab7" rid-ob="ob-Tab7" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table7).</span></span><span>7</span></a>). The -1031 CT and CC genotypes were more frequent in SARS patients with femoral head necrosis(53.7% and 6.7%, respectively) than in non-femoral head necrosis(20.0% and 0.0%, respectively). Compared to TT genotype, CT and CC were found associated with a risk effect on femoral head necrosis with ORs(95%<em>CI</em>) of 5.33(1.39&#x02013;20.45) and 5.67(2.74&#x02013;11.71), respectively. The adjusted OR of CT was 5.25(95%CI 1.18&#x02013;23.46) and the combined (CT and CC) genotype OR was 6.0 (95%CI 1.60&#x02013;22.55). Also, the -863 AC genotype accounted for 43.7% of femoral head necrosis group but 10.8% of non-femoral head necrosis. Compared to CC genotype, the AC genotype was manifested as another risk effect associated with femoral head necrosis with OR(95%CI) of 6.42(1.53&#x02013;26.88) and the adjusted OR was 8.40(95%CI 1.76&#x02013;40.02) in cured SARS patients.\n</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab7"><h3>Table 7</h3><!--caption a7--><div class="caption"><p id="__p40">\n<em>TNF</em>-&#x003b1; gene polymorphism and femoral head necrosis in cured SARS patients.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140321571310720" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">SNP site</th><th align="center" rowspan="1" colspan="1">Femoral head necrosis (%)</th><th align="center" rowspan="1" colspan="1">Non-femoral head necrosis (%)</th><th align="center" rowspan="1" colspan="1">OR* (95%C.I.)</th><th align="center" rowspan="1" colspan="1">\n<em>P</em>\n</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">-1031</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">TT</td><td align="center" rowspan="1" colspan="1">6(40)</td><td align="center" rowspan="1" colspan="1">28(80)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">8(53.7)</td><td align="center" rowspan="1" colspan="1">7(20)</td><td align="center" rowspan="1" colspan="1">5.33(1.39&#x02013;20.45)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">1(6.7)</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">5.67(2.74&#x02013;11.71)<sup>$</sup>\n</td><td align="center" rowspan="1" colspan="1">0.04</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">66.67</td><td align="center" rowspan="1" colspan="1">90.00</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">33.33</td><td align="center" rowspan="1" colspan="1">10.00</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-863</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">9(56.3)</td><td align="center" rowspan="1" colspan="1">33(89.2)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">7(43.7)</td><td align="center" rowspan="1" colspan="1">4(10.8)</td><td align="center" rowspan="1" colspan="1">6.42(1.53&#x02013;26.88)</td><td align="center" rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">78.12</td><td align="center" rowspan="1" colspan="1">94.59</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">21.88</td><td align="center" rowspan="1" colspan="1">5.41</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-857</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CC</td><td align="center" rowspan="1" colspan="1">12(75)</td><td align="center" rowspan="1" colspan="1">26(70.3)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">CT</td><td align="center" rowspan="1" colspan="1">4(25)</td><td align="center" rowspan="1" colspan="1">11(29.7)</td><td align="center" rowspan="1" colspan="1">0.78(0.21&#x02013;2.99)</td><td align="center" rowspan="1" colspan="1">0.73</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">87.50</td><td align="center" rowspan="1" colspan="1">85.14</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">T</td><td align="center" rowspan="1" colspan="1">12.50</td><td align="center" rowspan="1" colspan="1">14.86</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-572</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">16(100)</td><td align="center" rowspan="1" colspan="1">36(97.3)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AC</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1(2.7)</td><td align="center" rowspan="1" colspan="1">1.44(1.21&#x02013;1.73)<sup>&#x02021;</sup>\n</td><td align="center" rowspan="1" colspan="1">0.70</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">100</td><td align="center" rowspan="1" colspan="1">98.7</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">C</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1.3</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-308</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">14(87.5)</td><td align="center" rowspan="1" colspan="1">32(86.5)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">2(12.5)</td><td align="center" rowspan="1" colspan="1">4(10.8)</td><td align="center" rowspan="1" colspan="1">1.14(0.19&#x02013;6.98)</td><td align="center" rowspan="1" colspan="1">0.89</td></tr><tr><td align="center" rowspan="1" colspan="1">AA</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">1(2.7)</td><td align="center" rowspan="1" colspan="1">1.44(1.19&#x02013;1.74)<sup>&#x02021;</sup>\n</td><td align="center" rowspan="1" colspan="1">0.70</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">93.37</td><td align="center" rowspan="1" colspan="1">91.89</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">6.25</td><td align="center" rowspan="1" colspan="1">8.11</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">-238</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Genotype</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">GG</td><td align="center" rowspan="1" colspan="1">13(81.3)</td><td align="center" rowspan="1" colspan="1">33(89.2)</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">AG</td><td align="center" rowspan="1" colspan="1">3(18.7)</td><td align="center" rowspan="1" colspan="1">4(10.8)</td><td align="center" rowspan="1" colspan="1">1.90(0.37&#x02013;9.71)</td><td align="center" rowspan="1" colspan="1">0.35</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02003;&#x02003;Allele</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">G</td><td align="center" rowspan="1" colspan="1">90.62</td><td align="center" rowspan="1" colspan="1">94.59</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td align="center" rowspan="1" colspan="1">A</td><td align="center" rowspan="1" colspan="1">9.38</td><td align="center" rowspan="1" colspan="1">5.41</td><td rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr></tbody></table></div><div id="largeobj_idm140321571310720" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2291466/table/Tab7/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p41">Note: *:OR was calculated using non-femoral head necrosis as control.</p><p id="__p42">$:OR replaced by femoral head necrosis;</p><p id="__p43">&#x02021;: OR estimated by non-femoral head necrosis;</p></div></div></div></div><div id="Sec13" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec13title">Discussion</h2><p id="__p44" class="p p-first">Four years after SARS occurrence, many problems still remained unknown to us. Till now, many researchers have reported that susceptibility to infection SARS-CoV may associate with HLA, MXA, OAS-1 and CLEC4M gene polymorphisms, yet the results are variable in different populations [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014098">9</a>&#x02013;<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199751">13</a>]. These differences may be attributed to the study population used in each report, also the complex mechanism infection to SARS-CoV should be considered as another factor of these differences. In order to explore more host factor influence the occurrence of SARS-CoV infection, we studied the polymorphisms of <em>TNF-&#x003b1;</em> gene at the promoter region, which have been ascribed to polymorphisms within the regulatory regions or signal sequences of cytokine genes [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014067">14</a>]. Allele distributions at -1031, -863, -857, -572, -238 and -163 were almost the same among the SARS, the health care workers and individual controls, but a higher A allele frequency in SARS population when compared with the control at the -308 locus(<em>X</em>\n<sup>2</sup> = 8.96, <em>P</em> = 0.003). Though previous study showed that <em>TNF-&#x003b1;</em> -308 AG genotype was associated with the clearance of Hepatitis B virus and the infection of <em>Helicobacter pylori</em> cagA subtype infection [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014071">24</a>, <a href="#CR25" rid="CR25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014062">25</a>], our results failed to show the role of this locus in SARS-CoV infection and this conclusion agreed with that of Chong WP <em>et al</em> [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199757">26</a>]. We found that there was a weak protective effect of CT genotype at -204 locus of <em>TNF-&#x003b1;</em> gene against SARS-CoV infection. The -204 locus was a new discovered SNP site of <em>TNF-&#x003b1;</em> promoter region and its role in infectious diseases might need further study. At the same time, no obvious association between the polymorphisms of <em>TNF-&#x003b1;</em> promoter region with the severity of SARS was observed. However, Lu reported that the -238G/A polymorphism of <em>TNF-&#x003b1;</em> associated with the outcomes of hepatitis B virus infection [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014057">27</a>]. Thus, the roles of <em>TNF-&#x003b1;</em> gene in infectious diseases should be further studied.</p><p id="__p45">TNF-&#x003b1;, a key mediator of the inflammatory response, is critical for host defense against a wide variety of pathogenic microbes, but a higher concentration of this cytokine may cause severe pathology. The capacity for cytokine production in an individual has a major genetic component, and striking differences existed among individuals in terms of their ability to produce cytokines. A number of studies had shown that the <em>TNF-&#x003b1;</em> promoter polymorphism has a significant effect on transcriptional activity [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014076">6</a>, <a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199750">7</a>]. During the process of SARS-CoV infection, there was a cytokine storm in patients including IL-1, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-&#x003b3;, TNF-&#x003b1; and TGF-&#x003b2;<sub>1</sub> [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014085">28</a>]. The elevated levels of pro-inflammatory cytokines which may cause immuno-mediated damage to lung and other organs, resulting in acute lung injury and, subsequently, multi-organ dysfunction [<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014075">29</a>]. So, <em>TNF-&#x003b1;</em> genetic variation may potentially alter inflammation and fibrosis in the lung. After discharging from hospital, interstitial lung fibrosis was observed in cured SARS patients and the prevalence rate was 21%(42/200). TNF-&#x003b1; was one of the earliest cytokines implicated in the pathogenesis of lung fibrosis disease and, together with IL-1, has been found to over-express in regenerating type II pneumocytes in human lung, thus enhancing fibroblast proliferation [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014081">16</a>].<em>TNF-&#x003b1;</em> genetic polymorphisms have been found significantly associated with increased risk of developing pulmonary fibrosis [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199752">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014091">18</a>]. During the progress of idiopathic pulmonary fibrosis, activated epithelial cells are thought to release potent fibrogenic molecules and cytokines, such as TNF-&#x003b1; and TGF-&#x003b2;<sub>1</sub>, which in turn foster the transformation of fibroblasts into myofibroblasts and promote their production of extracellular matrix molecules and a vicious cycle of injury and abnormal epithelial healing sets the stage for progressive fibrosis and architectural distortion of the lung parenchyma [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199756">7</a>]. However, our data failed to show that alleles at -1031(T&#x02192;C), -863(C&#x02192;A), -857(C&#x02192;T), -572(A&#x02192;C), -308(G&#x02192;A) and -238(G&#x02192;A) were related to interstitial lung fibrosis when compared with non-interstitial lung fibrosis in SARS patients. At the same time, -204 and -163 were homozygote genotype of TT and GG respectively in SARS patients and no relationship of genotype with interstitial lung fibrosis could be calculated. This result implicated that there maybe a different mechanism of interstitial lung fibrosis of SARS compared with idiopathic pulmonary fibrosis.</p><p id="__p46" class="p p-last">Femoral head necrosis, another sequela of discharged SARS patients, prevailed with a rate of 22.07%(49/221) in Tianjin [<a href="#CR15" rid="CR15" class=" bibr popnode">15</a>]. However, the cause of this sequela was still unknown and there were arguments about it. For example, some author considered SARS-CoV as the cause of femoral head necrosis, yet other authors disagree with this view [<a href="#CR20" rid="CR20" class=" bibr popnode">20</a>, <a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014077">21</a>]. Previous studies showed that femoral head necrosis may caused by hormone usage, our data was far to agree with this conclusion. There was no obvious association between hormone using including hormone dosage, method and lasting period with femoral head necrosis in binary logistic analysis in SARS patients. We found that the -1031 CT and CC genotypes were more frequent in SARS patients with femoral head necrosis(53.7% and 6.7%, respectively) than in non-femoral head necrosis(20.0% and 0.0%, respectively). And CT and CC were related with a risk effect on femoral head necrosis with ORs (95%<em>CI</em>) of 5.33(1.39&#x02013;20.45) and 5.67(2.74&#x02013;11.71), respectively when compared to TT genotype. The hormone using adjusted OR of CT was 5.25(95%CI 1.18&#x02013;23.46) and the combined (CT and CC) genotype OR was 6.0 (95%CI 1.60&#x02013;22.55). Also, the -863 AC genotype accounted for 43.7% of femoral head necrosis group but 10.8% of non-femoral head necrosis. Compared to CC genotype, the AC genotype was manifested as another risk effect associated with femoral head necrosis with OR(95%CI) of 6.42(1.53&#x02013;26.88) and the adjusted OR was 8.40(95%CI 1.76&#x02013;40.02) in cured SARS patients. TNF-&#x003b1; can activate activity of osteoclasts and accelerate absorption of the bone and cartilage and induce occurrence of oxygen free radicals an d lipid peroxidation, which can induce ischemic necrosis of the femoral head [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844014069">30</a>]. So, the ploymophism <em>TNF-&#x003b1;</em> gene may be directly or indirectly attributed to the occurrence of femoral head necrosis in SARS patients.</p></div><div id="Sec14" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec14title">Conclusion</h2><p id="__p47" class="p p-first-last">In conclusion, there may be no association of <em>TNF</em>-&#x003b1; polymorphisms in promoter region with SARS-Cov infection. Also, <em>TNF-&#x003b1;</em> gene polymorphisms may no affect the occurrence of interstitial lung fibrosis in cured SARS patients. However, the polymorphisms may relate with femoral head necrosis.</p></div><div id="idm140321501223136" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140321501223136title">Acknowledgements</h2><div class="sec"><p id="__p59">This paper was supported by the Tianjin Science Fund (No. 05YFSZSF02900) and the Science Fund of Medical College of CPAFP(No. WY-2005-14).</p></div></div><div id="idm140321504270960" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140321504270960title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140321504270832"><p id="__p48" class="p p-first-last">Shixin Wang, Maoti Wei contributed equally to this work.</p></p><p class="fn sec" id="idm140321504270112"><p id="__p49" class="p p-first"><strong>Competing interests</strong></p><p id="__p50" class="p p-last">The author(s) declare that they have no competing interests.</p></p><p class="fn sec" id="idm140321504268704"><p id="__p51" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p52" class="p">SXW conceived of the study, and participated in its design and coordination.</p><p id="__p53" class="p">MTW, co-first author, carried out the molecular genetic studies and drafted the manuscript.</p><p id="__p54" class="p">YH, KJZ and LH carried out the molecular genetic studies</p><p id="__p55" class="p">ZY, BS and ZLZ participated in field investigation and samples collection of the study</p><p id="__p56" class="p">YLH and WLH participated in the design of the study and performed the statistical analysis</p><p id="__p57" class="p">All authors contributed to writing of the final manuscript</p><p id="__p58" class="p p-last">All authors read and approved the final manuscript</p></p></div></div><div id="idm140321497941264aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140321497941264aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Shixin Wang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@100-xhsW" class="oemail">moc.361@100-xhsW</a></span>.</p><p><span class="fm-affl">Maoti Wei, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.oohay@itoamiew" class="oemail">nc.moc.oohay@itoamiew</a></span>.</p><p><span class="fm-affl">Yi Han, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@hs1002nahnalah" class="oemail">moc.361@hs1002nahnalah</a></span>.</p><p><span class="fm-affl">Keju Zhang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.anis@77gnonis" class="oemail">moc.anis@77gnonis</a></span>.</p><p><span class="fm-affl">Li He, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@lhnijuw" class="oemail">moc.361@lhnijuw</a></span>.</p><p><span class="fm-affl">Zhen Yang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.oohay@anihctdzy" class="oemail">nc.moc.oohay@anihctdzy</a></span>.</p><p><span class="fm-affl">Bing Su, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.anis@355nibusjt" class="oemail">moc.anis@355nibusjt</a></span>.</p><p><span class="fm-affl">Zhilun Zhang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.anis@817lzz" class="oemail">nc.moc.anis@817lzz</a></span>.</p><p><span class="fm-affl">Yilan Hu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.oohay@uguoy" class="oemail">nc.moc.oohay@uguoy</a></span>.</p><p><span class="fm-affl">Wuli Hui, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.361@iluwiuh" class="oemail">moc.361@iluwiuh</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">The MHC sequencing consortium  Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. <span><span class="ref-journal">Nature. </span>1999;<span class="ref-vol">401</span>:921\xe2\x80\x93923. doi: 10.1038/44853.</span> [<a href="/pubmed/10553908" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2F44853" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Complete+sequence+and+gene+map+of+a+human+major+histocompatibility+complex.+The+MHC+sequencing+consortium&amp;volume=401&amp;publication_year=1999&amp;pages=921-923&amp;pmid=10553908&amp;doi=10.1038/44853&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Sariban E, Imamura K, Luebbers R, Kufe D. Transcriptional and posttranscriptional regulation of tumor necrosis factor gene expression in human monocytes. <span><span class="ref-journal">J Clin Invest. </span>1988;<span class="ref-vol">81</span>:1506\xe2\x80\x9310. doi: 10.1172/JCI113482.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC442583/">PMC free article</a>]</span> [<a href="/pubmed/3366904" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1172%2FJCI113482" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Invest&amp;title=Transcriptional+and+posttranscriptional+regulation+of+tumor+necrosis+factor+gene+expression+in+human+monocytes&amp;author=E+Sariban&amp;author=K+Imamura&amp;author=R+Luebbers&amp;author=D+Kufe&amp;volume=81&amp;publication_year=1988&amp;pages=1506-10&amp;pmid=3366904&amp;doi=10.1172/JCI113482&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Richardson A, Sisay-Joof F, Ackerman H, Usen S, Katundu P, Taylor T, Molyneux M, Pinder M, Kwiatkowski D. Nucleotide diversity of the TNF gene region in an African village. <span><span class="ref-journal">Genes and Immunity. </span>2001;<span class="ref-vol">2</span>:343\xe2\x80\x93348. doi: 10.1038/sj.gene.6363789.</span> [<a href="/pubmed/11607791" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fsj.gene.6363789" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genes+and+Immunity&amp;title=Nucleotide+diversity+of+the+TNF+gene+region+in+an+African+village&amp;author=A+Richardson&amp;author=F+Sisay-Joof&amp;author=H+Ackerman&amp;author=S+Usen&amp;author=P+Katundu&amp;volume=2&amp;publication_year=2001&amp;pages=343-348&amp;pmid=11607791&amp;doi=10.1038/sj.gene.6363789&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K. Polymorphism of the 5\'-flanking region of the human tumor necrosis factor (TNF)-alpha gene in Japanese. <span><span class="ref-journal">Tissue Antigens. </span>1998;<span class="ref-vol">51</span>:605\xe2\x80\x93612. doi: 10.1111/j.1399-0039.1998.tb03002.x.</span> [<a href="/pubmed/9694352" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1399-0039.1998.tb03002.x" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Tissue+Antigens&amp;title=Polymorphism+of+the+5\'-flanking+region+of+the+human+tumor+necrosis+factor+(TNF)-alpha+gene+in+Japanese&amp;author=T+Higuchi&amp;author=N+Seki&amp;author=S+Kamizono&amp;author=A+Yamada&amp;author=A+Kimura&amp;volume=51&amp;publication_year=1998&amp;pages=605-612&amp;pmid=9694352&amp;doi=10.1111/j.1399-0039.1998.tb03002.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Juszczynski P, Kalinka E, Bienvenu J, Woszczek G, Borowiec M, Robak T, Kowalski M, Lech ME, Baseggio L, Coiffier B, et al.  Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome. <span><span class="ref-journal">Blood. </span>2002;<span class="ref-vol">100</span>:3037\xe2\x80\x933040. doi: 10.1182/blood-2002-02-0654.</span> [<a href="/pubmed/12351419" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1182%2Fblood-2002-02-0654" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Human+leukocyte+antigens+class+II+and+tumor+necrosis+factor+genetic+polymorphisms+are+independent+predictors+of+non-Hodgkin+lymphoma+outcome&amp;author=P+Juszczynski&amp;author=E+Kalinka&amp;author=J+Bienvenu&amp;author=G+Woszczek&amp;author=M+Borowiec&amp;volume=100&amp;publication_year=2002&amp;pages=3037-3040&amp;pmid=12351419&amp;doi=10.1182/blood-2002-02-0654&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. <span><span class="ref-journal">Mol Immunol. </span>1997;<span class="ref-vol">34</span>:391\xe2\x80\x93399. doi: 10.1016/S0161-5890(97)00052-7.</span> [<a href="/pubmed/9293772" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0161-5890(97)00052-7" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Mol+Immunol&amp;title=The+-308+tumor+necrosis+factor-alpha+promoter+polymorphism+effects+transcription&amp;author=KM+Kroeger&amp;author=KS+Carville&amp;author=LJ+Abraham&amp;volume=34&amp;publication_year=1997&amp;pages=391-399&amp;pmid=9293772&amp;doi=10.1016/S0161-5890(97)00052-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Verma S, Slutsky AS. Idiopathic Pulmonary Fibrosis-New Insights. <span><span class="ref-journal">N Eng J Med. </span>2007;<span class="ref-vol">356</span>(13):1370\xe2\x80\x931371. doi: 10.1056/NEJMcibr070490.</span> [<a href="/pubmed/17392309" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMcibr070490" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Eng+J+Med&amp;title=Idiopathic+Pulmonary+Fibrosis-New+Insights&amp;author=S+Verma&amp;author=AS+Slutsky&amp;volume=356&amp;issue=13&amp;publication_year=2007&amp;pages=1370-1371&amp;doi=10.1056/NEJMcibr070490&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt GM, Ahuja A, Yung MY, Leung CB, To KF, Lui SF, Szeto CC, Chung S, Sung JJ. A major outbreak of severe acute respiratory syndrome in Hong Kong. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1986\xe2\x80\x9394. doi: 10.1056/NEJMoa030685.</span> [<a href="/pubmed/12682352" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa030685" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+major+outbreak+of+severe+acute+respiratory+syndrome+in+Hong+Kong&amp;author=N+Lee&amp;author=D+Hui&amp;author=A+Wu&amp;author=P+Chan&amp;author=P+Cameron&amp;volume=348&amp;publication_year=2003&amp;pages=1986-94&amp;pmid=12682352&amp;doi=10.1056/NEJMoa030685&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Ng MH, Lau KM, Li L, Cheng SH, Chan WY, Hui PK, Zee B, Leung CB, Sung JJ. Association of Human-Leukocyte-Antigen Class I (B*0703) and Class II (DRB1*0301) Genotypes with Susceptibility and Resistance to the Development of Severe Acute Respiratory Syndrome. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">190</span>(3):515\xe2\x80\x938. doi: 10.1086/421523.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7109646/">PMC free article</a>]</span> [<a href="/pubmed/15243926" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F421523" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Association+of+Human-Leukocyte-Antigen+Class+I+(B*0703)+and+Class+II+(DRB1*0301)+Genotypes+with+Susceptibility+and+Resistance+to+the+Development+of+Severe+Acute+Respiratory+Syndrome&amp;author=MH+Ng&amp;author=KM+Lau&amp;author=L+Li&amp;author=SH+Cheng&amp;author=WY+Chan&amp;volume=190&amp;issue=3&amp;publication_year=2004&amp;pages=515-8&amp;pmid=15243926&amp;doi=10.1086/421523&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Lin M, Tseng HK, Trejaut JA, Lee HL, Loo JH, Chu CC, Chen PJ, Su YW, Lim KH, Tsai ZU, Lin RY, Lin RS, Huang CH. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. <span><span class="ref-journal">BMC Med Genet. </span>2003;<span class="ref-vol">4</span>(1):9. doi: 10.1186/1471-2350-4-9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC212558/">PMC free article</a>]</span> [<a href="/pubmed/12969506" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1471-2350-4-9" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Med+Genet&amp;title=Association+of+HLA+class+I+with+severe+acute+respiratory+syndrome+coronavirus+infection&amp;author=M+Lin&amp;author=HK+Tseng&amp;author=JA+Trejaut&amp;author=HL+Lee&amp;author=JH+Loo&amp;volume=4&amp;issue=1&amp;publication_year=2003&amp;pages=9&amp;pmid=12969506&amp;doi=10.1186/1471-2350-4-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">He J, Feng D, de Vlas SJ, Wang H, Fontanet A, Zhang P, Plancoulaine S, Tang F, Zhan L, Yang H, Wang T, Richardus JH, Habbema JD, Cao W. Association of SARS susceptibility with single nucleic acid polymorphism of OAS-1 and MxA gene: a case-control study. <span><span class="ref-journal">BMC Infectious Disease. </span>2006;<span class="ref-vol">6</span>:106\xe2\x80\x93112. doi: 10.1186/1471-2334-6-106.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1550407/">PMC free article</a>]</span> [<a href="/pubmed/16824203" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1471-2334-6-106" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Infectious+Disease&amp;title=Association+of+SARS+susceptibility+with+single+nucleic+acid+polymorphism+of+OAS-1+and+MxA+gene:+a+case-control+study&amp;author=J+He&amp;author=D+Feng&amp;author=SJ+de+Vlas&amp;author=H+Wang&amp;author=A+Fontanet&amp;volume=6&amp;publication_year=2006&amp;pages=106-112&amp;doi=10.1186/1471-2334-6-106&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Hamano E, Hijikata M, Itoyama S, Quy T, Phi NC, Long HT, Ha le D, Ban VV, Matsushita I, Yanai H, Kirikae F, Kirikae T, Kuratsuji T, Sasazuki T, Keicho N. Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population. <span><span class="ref-journal">Biochemical and Biophysical Research Communications. </span>2005;<span class="ref-vol">329</span>(4):1234\xe2\x80\x931239. doi: 10.1016/j.bbrc.2005.02.101.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7092916/">PMC free article</a>]</span> [<a href="/pubmed/15766558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.bbrc.2005.02.101" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochemical+and+Biophysical+Research+Communications&amp;title=Polymorphisms+of+interferon-inducible+genes+OAS-1+and+MxA+associated+with+SARS+in+the+Vietnamese+population&amp;author=E+Hamano&amp;author=M+Hijikata&amp;author=S+Itoyama&amp;author=T+Quy&amp;author=NC+Phi&amp;volume=329&amp;issue=4&amp;publication_year=2005&amp;pages=1234-1239&amp;pmid=15766558&amp;doi=10.1016/j.bbrc.2005.02.101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Chan VS, Chan KY, Chen Y, Poon LL, Cheung AN, Zheng B, Chan KH, Mak W, Ngan HY, Xu X, Screaton G, Tam PK, Austyn JM, Chan LC, Yip SP, Peiris M, Khoo US, Lin CL. Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>(1):38\xe2\x80\x9346. doi: 10.1038/ng1698.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7097088/">PMC free article</a>]</span> [<a href="/pubmed/16369534" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fng1698" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Genet&amp;title=Homozygous+L-SIGN+(CLEC4M)+plays+a+protective+role+in+SARS+coronavirus+infection&amp;author=VS+Chan&amp;author=KY+Chan&amp;author=Y+Chen&amp;author=LL+Poon&amp;author=AN+Cheung&amp;volume=38&amp;issue=1&amp;publication_year=2006&amp;pages=38-46&amp;pmid=16369534&amp;doi=10.1038/ng1698&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. <span><span class="ref-journal">Clin Exp Immunol. </span>1995;<span class="ref-vol">99</span>(2):303\xe2\x80\x93310. doi: 10.1111/j.1365-2249.1995.tb05549.x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1534297/">PMC free article</a>]</span> [<a href="/pubmed/7851026" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1365-2249.1995.tb05549.x" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Immunol&amp;title=Cytokine+production+by+normal+human+monocytes:+inter-subject+variation+and+relationship+to+an+IL-1+receptor+antagonist+(IL-1Ra)+gene+polymorphism&amp;author=VA+Danis&amp;author=M+Millington&amp;author=VJ+Hyland&amp;author=D+Grennan&amp;volume=99&amp;issue=2&amp;publication_year=1995&amp;pages=303-310&amp;pmid=7851026&amp;doi=10.1111/j.1365-2249.1995.tb05549.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Jiao ZS, Yuan SL, Cao Q, Wang SX, Wu HW, Yang Z, Su B, Yu QC, Lu WY, Li YC, Tian HG, Zhang Y. The Follow-up Study on the Health Status of Convalescent Patienrs Recovered from SARS in Tianjin. <span><span class="ref-journal">Chinese Journal of Prevention and control of Chronic non-communicable Diseases. </span>2006;<span class="ref-vol">14</span>(6):175\xe2\x80\x93178.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chinese+Journal+of+Prevention+and+control+of+Chronic+non-communicable+Diseases&amp;title=The+Follow-up+Study+on+the+Health+Status+of+Convalescent+Patienrs+Recovered+from+SARS+in+Tianjin&amp;author=ZS+Jiao&amp;author=SL+Yuan&amp;author=Q+Cao&amp;author=SX+Wang&amp;author=HW+Wu&amp;volume=14&amp;issue=6&amp;publication_year=2006&amp;pages=175-178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Pan LH, Ohtani H, Yamauchi K, Nagura H. Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. <span><span class="ref-journal">Pathol Int. </span>1996;<span class="ref-vol">46</span>(2):91\xe2\x80\x939. doi: 10.1111/j.1440-1827.1996.tb03584.x.</span> [<a href="/pubmed/10846556" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1440-1827.1996.tb03584.x" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pathol+Int&amp;title=Co-expression+of+TNF+alpha+and+IL-1+beta+in+human+acute+pulmonary+fibrotic+diseases:+an+immunohistochemical+analysis&amp;author=LH+Pan&amp;author=H+Ohtani&amp;author=K+Yamauchi&amp;author=H+Nagura&amp;volume=46&amp;issue=2&amp;publication_year=1996&amp;pages=91-9&amp;pmid=10846556&amp;doi=10.1111/j.1440-1827.1996.tb03584.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Whyte M, Hubbard R, Meliconi R, Whidborne M, Eaton V, Bingle C, Timms J, Duff G, Facchini A, Pacilli A, Fabbri M, Hall I, Britton J, Johnston I, Di Giovine F. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-a gene polymorphisms. <span><span class="ref-journal">Am J Respir Crit Care. </span>2000;<span class="ref-vol">162</span>(2 Pt 1):755\xe2\x80\x938. doi: 10.1164/ajrccm.162.2.9909053.</span> [<a href="/pubmed/10934117" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm.162.2.9909053" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care&amp;title=Increased+risk+of+fibrosing+alveolitis+associated+with+interleukin-1+receptor+antagonist+and+tumor+necrosis+factor-a+gene+polymorphisms&amp;author=M+Whyte&amp;author=R+Hubbard&amp;author=R+Meliconi&amp;author=M+Whidborne&amp;author=V+Eaton&amp;volume=162&amp;issue=2+Pt+1&amp;publication_year=2000&amp;pages=755-8&amp;doi=10.1164/ajrccm.162.2.9909053&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor-a, lymphotoxin-a, tumor necrosis factor receptor II and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. <span><span class="ref-journal">Am J Resp Crit Care Med. </span>2001;<span class="ref-vol">163</span>(6):1432\xe2\x80\x936. doi: 10.1164/ajrccm.163.6.2006064.</span> [<a href="/pubmed/11371414" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm.163.6.2006064" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Resp+Crit+Care+Med&amp;title=Analysis+of+tumor+necrosis+factor-a,+lymphotoxin-a,+tumor+necrosis+factor+receptor+II+and+interleukin-6+polymorphisms+in+patients+with+idiopathic+pulmonary+fibrosis&amp;author=P+Pantelidis&amp;author=GC+Fanning&amp;author=AU+Wells&amp;author=KI+Welsh&amp;author=RM+Du+Bois&amp;volume=163&amp;issue=6&amp;publication_year=2001&amp;pages=1432-6&amp;pmid=11371414&amp;doi=10.1164/ajrccm.163.6.2006064&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Xie L, Liu Y, Fan B, Xiao Y, Tian Q, Chen L, Zhao H, Chen W. Dynamic changes of serum SARS-Coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge. <span><span class="ref-journal">Respiratory Research. </span>2005;<span class="ref-vol">6</span>:5\xe2\x80\x9311. doi: 10.1186/1465-9921-6-5.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC545044/">PMC free article</a>]</span> [<a href="/pubmed/15638943" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1465-9921-6-5" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Respiratory+Research&amp;title=Dynamic+changes+of+serum+SARS-Coronavirus+IgG,+pulmonary+function+and+radiography+in+patients+recovering+from+SARS+after+hospital+discharge&amp;author=L+Xie&amp;author=Y+Liu&amp;author=B+Fan&amp;author=Y+Xiao&amp;author=Q+Tian&amp;volume=6&amp;publication_year=2005&amp;pages=5-11&amp;pmid=15638943&amp;doi=10.1186/1465-9921-6-5&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Gao HS, Wang SX, Cao X, Hui WL, Li YM, Yang Z, SU B. Nested case-control study of avascular necrosis of femoral head during SARS patients\' convalescence. <span><span class="ref-journal">Acta Academiae Medicinae CPAPF. </span>2005;<span class="ref-vol">14</span>(1):11\xe2\x80\x9313.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Academiae+Medicinae+CPAPF&amp;title=Nested+case-control+study+of+avascular+necrosis+of+femoral+head+during+SARS+patients\'+convalescence&amp;author=HS+Gao&amp;author=SX+Wang&amp;author=X+Cao&amp;author=WL+Hui&amp;author=YM+Li&amp;volume=14&amp;issue=1&amp;publication_year=2005&amp;pages=11-13&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Li YM, Wang SX, Gao HS, Wang JG, Wei CS, Chen LM, Hui WL, Yuan SL, Jiao ZS, Yang Z, Su B. Factors of avascular necrosis of femoral head and osteoporosis in SARS patients\' convalescence. <span><span class="ref-journal">Zhonghua Yi Xue Za Zhi. </span>2004;<span class="ref-vol">84</span>(16):1348\xe2\x80\x9353.</span> [<a href="/pubmed/15387943" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Zhonghua+Yi+Xue+Za+Zhi&amp;title=Factors+of+avascular+necrosis+of+femoral+head+and+osteoporosis+in+SARS+patients\'+convalescence&amp;author=YM+Li&amp;author=SX+Wang&amp;author=HS+Gao&amp;author=JG+Wang&amp;author=CS+Wei&amp;volume=84&amp;issue=16&amp;publication_year=2004&amp;pages=1348-53&amp;pmid=15387943&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="mixed-citation">Chinese Ministry of Health: Proposal for therapy and diagnosis of SARS,2004 edition issued by Chinese Ministry of Health in 2004. Accessed 3rd April 2008, [<a href="http://www.jdzx.net.cn/editor/UploadFile//20060703105949294.doc" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.jdzx.net.cn/editor/UploadFile//20060703105949294.doc</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Gewaltig J, Mangasser-Stephan K, Gartung C, Biesterfeld S, Gressner AM. Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. <span><span class="ref-journal">Clin Chim Acta. </span>2002;<span class="ref-vol">316</span>(1&#x02013;2):83\xe2\x80\x9394. doi: 10.1016/S0009-8981(01)00738-0.</span> [<a href="/pubmed/11750277" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0009-8981(01)00738-0" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chim+Acta&amp;title=Association+of+polymorphisms+of+the+transforming+growth+factor-beta1+gene+with+the+rate+of+progression+of+HCV-induced+liver+fibrosis&amp;author=J+Gewaltig&amp;author=K+Mangasser-Stephan&amp;author=C+Gartung&amp;author=S+Biesterfeld&amp;author=AM+Gressner&amp;volume=316&amp;issue=1&#x02013;2&amp;publication_year=2002&amp;pages=83-94&amp;pmid=11750277&amp;doi=10.1016/S0009-8981(01)00738-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Kim YJ, Lee HS, Yoon JH, Kim CY, Park MH, Kim LH, Park BL, Shin HD. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. <span><span class="ref-journal">Human Molecular Genetics. </span>2003;<span class="ref-vol">12</span>(19):2541\xe2\x80\x932546. doi: 10.1093/hmg/ddg262.</span> [<a href="/pubmed/12915457" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fhmg%2Fddg262" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Molecular+Genetics&amp;title=Association+of+TNF-alpha+promoter+polymorphisms+with+the+clearance+of+hepatitis+B+virus+infection&amp;author=YJ+Kim&amp;author=HS+Lee&amp;author=JH+Yoon&amp;author=CY+Kim&amp;author=MH+Park&amp;volume=12&amp;issue=19&amp;publication_year=2003&amp;pages=2541-2546&amp;pmid=12915457&amp;doi=10.1093/hmg/ddg262&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between <em>TNF-&#x003b1;</em> promoter polymorphism and <em>Helicobacter pylori</em>cagA subtype infection. <span><span class="ref-journal">J Clin Pathol. </span>2001;<span class="ref-vol">54</span>(9):703\xe2\x80\x93706. doi: 10.1136/jcp.54.9.703.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1731516/">PMC free article</a>]</span> [<a href="/pubmed/11533078" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fjcp.54.9.703" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Pathol&amp;title=Association+between+TNF-&#x003b1;+promoter+polymorphism+and+Helicobacter+pyloricagA+subtype+infection&amp;author=SS+Yea&amp;author=YI+Yang&amp;author=WH+Jang&amp;author=YJ+Lee&amp;author=HS+Bae&amp;volume=54&amp;issue=9&amp;publication_year=2001&amp;pages=703-706&amp;pmid=11533078&amp;doi=10.1136/jcp.54.9.703&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="mixed-citation">Chong WP, Ip WK, Tso GH, Ng MW, Wong WH, Law HK, Yung RW, Chow EY, Au KL, Chan EY, Lim W, Peiris JS, Lau YL: The interferon gamma gene polymorphism +874 A/T is associated with severe acute respiratory syndrome. BMC Infect Dis. 6: 82-10.1186/1471-2334-6-82. 2006 May 4 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1468415/">PMC free article</a>]</span> [<a href="/pubmed/16672072" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Lu LP, Li XW, Liu Y, Sun GC, Wang XP, Zhu XL, Hu QY, Li H. Association of -238G/A polymorphism of tumor necrosis factor-alpha gene promoter region with outcomes of hepatitis B virus infection in Chinese Han population. <span><span class="ref-journal">World J Gastroenterol. </span>2004;<span class="ref-vol">10</span>(12):1810\xe2\x80\x931814. doi: 10.3748/wjg.v10.i12.1810.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4572275/">PMC free article</a>]</span> [<a href="/pubmed/15188512" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.3748%2Fwjg.v10.i12.1810" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Association+of+-238G/A+polymorphism+of+tumor+necrosis+factor-alpha+gene+promoter+region+with+outcomes+of+hepatitis+B+virus+infection+in+Chinese+Han+population&amp;author=LP+Lu&amp;author=XW+Li&amp;author=Y+Liu&amp;author=GC+Sun&amp;author=XP+Wang&amp;volume=10&amp;issue=12&amp;publication_year=2004&amp;pages=1810-1814&amp;pmid=15188512&amp;doi=10.3748/wjg.v10.i12.1810&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W, Ye L, Xu S, Sun R, Wang Y, Lou J. Analysis of serum cytokines in patients with severe acute respiratory syndrome. <span><span class="ref-journal">Infect Immun. </span>2004;<span class="ref-vol">72</span>(8):4410\xe2\x80\x935. doi: 10.1128/IAI.72.8.4410-4415.2004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC470699/">PMC free article</a>]</span> [<a href="/pubmed/15271897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FIAI.72.8.4410-4415.2004" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infect+Immun&amp;title=Analysis+of+serum+cytokines+in+patients+with+severe+acute+respiratory+syndrome&amp;author=Y+Zhang&amp;author=J+Li&amp;author=Y+Zhan&amp;author=L+Wu&amp;author=X+Yu&amp;volume=72&amp;issue=8&amp;publication_year=2004&amp;pages=4410-5&amp;pmid=15271897&amp;doi=10.1128/IAI.72.8.4410-4415.2004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">He L, Ding Y, Zhang Q, Che X, He Y, Shen H, Wang H, Li Z, Zhao L, Geng J, Deng Y, Yang L, Li J, Cai J, Qiu L, Wen K, Xu X, Jiang S. Expression of elevated levels of pro-inflammatory cytokines in SARS-CoV-infected ACE2+ cells in SARS patients: relation to the acute lung injury and pathogenesis of SARS. <span><span class="ref-journal">J Pathol. </span>2006;<span class="ref-vol">210</span>(3):288\xe2\x80\x9397. doi: 10.1002/path.2067.</span> [<a href="/pubmed/17031779" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fpath.2067" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pathol&amp;title=Expression+of+elevated+levels+of+pro-inflammatory+cytokines+in+SARS-CoV-infected+ACE2++cells+in+SARS+patients:+relation+to+the+acute+lung+injury+and+pathogenesis+of+SARS&amp;author=L+He&amp;author=Y+Ding&amp;author=Q+Zhang&amp;author=X+Che&amp;author=Y+He&amp;volume=210&amp;issue=3&amp;publication_year=2006&amp;pages=288-97&amp;pmid=17031779&amp;doi=10.1002/path.2067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Yuan P, He X, Zhou H, Wang G, Wang D, Li H. Experimental study on gufusheng in treatment of steroid-induced ischemic necrosis of femoral head in rabbits. <span><span class="ref-journal">J Tradit Chin Med. </span>2005;<span class="ref-vol">25</span>(4):300\xe2\x80\x933.</span> [<a href="/pubmed/16447676" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Tradit+Chin+Med&amp;title=Experimental+study+on+gufusheng+in+treatment+of+steroid-induced+ischemic+necrosis+of+femoral+head+in+rabbits&amp;author=P+Yuan&amp;author=X+He&amp;author=H+Zhou&amp;author=G+Wang&amp;author=D+Wang&amp;volume=25&amp;issue=4&amp;publication_year=2005&amp;pages=300-3&amp;pmid=16447676&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div><div class="ref-list-sec sec" id="BSec1"><h2 id="BSec1title">Pre-publication history</h2><ul class="back-ref-list" style="list-style-type:decimal;"><li id="CR31"><span class="mixed-citation">The pre-publication history for this paper can be accessed here:<a href="http://www.biomedcentral.com/1471-2334/8/27/prepub" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2291466&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.biomedcentral.com/1471-2334/8/27/prepub</a></span></li></ul></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2291466/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2291466/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2291466/pdf/12879_2007_Article_618.pdf">PDF (243K)</a></li> | <li><a href="#" data-citationid="PMC2291466" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2291466%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2291466%2F&amp;text=Roles%20of%20TNF-%CE%B1%20gene%20polymorphisms%20in%20the%20occurrence%20and%20progress%20of%20SARS-Cov%20infection%3A%20A%20case-control%20study"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2291466%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18312678" data-aiid="7091202" data-aid="2291466" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2291466" data-md5="2673f8005b8ab8b38322400a0be45d8f"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:40:34-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1A451FE99B02F10000000001140111&amp;ncbi_session=8A1A451FE99B1D11_0276SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2291466%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2291466/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1A451FE99B1D11_0276SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'